Hangzhou Biotest Biotech Co Ltd (688767) — Capital Reinvestment Ratio
Hangzhou Biotest Biotech Co Ltd (688767) has a Capital Reinvestment Ratio of 1.66x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥28.39 Million) in capital expenditures (CN¥47.02 Million). Check Hangzhou Biotest Biotech Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Biotest Biotech Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Hangzhou Biotest Biotech Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Hangzhou Biotest Biotech Co Ltd (688767) cash conversion ratio.
Annual Capital Reinvestment Ratio for Hangzhou Biotest Biotech Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025. See 688767 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.22x | CN¥106.47 Million | CN¥129.87 Million | ▼ -35.9% |
| 2024 | 1.90x | CN¥128.83 Million | CN¥245.05 Million | ▲ +342.9% |
| 2023 | 0.43x | CN¥131.38 Million | CN¥56.42 Million | ▲ +68.8% |
| 2022 | 0.25x | CN¥703.21 Million | CN¥178.92 Million | ▲ +15.4% |
| 2021 | 0.22x | CN¥908.12 Million | CN¥200.20 Million | ▲ +70.5% |
| 2020 | 0.13x | CN¥446.07 Million | CN¥57.68 Million | ▼ -91.6% |
| 2019 | 1.54x | CN¥25.67 Million | CN¥39.47 Million | ▲ +157.0% |
| 2018 | 0.60x | CN¥21.17 Million | CN¥12.67 Million | ▼ -83.9% |
| 2017 | 3.73x | CN¥7.07 Million | CN¥26.37 Million | — |